Global Indices 17-Apr Prev_Day Abs. Change
Russell 3000 1,359 1,333 26 1.96
Nasdaq 8,650 8,532 118 1.38
FTSE 5,787 5,628 159 2.82
Nikkei 19,897 19,290 607 3.15
Hang Seng 24,380 24,006 374 1.56
Indian Indices 17-Apr Prev_Day Abs. Change
S&P BSE Sensex 31,589 30,603 986 3.22
Nifty 50 9,267 8,993 274 3.05
Nifty 100 9,454 9,197 256 2.79
Nifty 500 7,614 7,412 202 2.73
Nifty Bank 20,681 19,400 1,281 6.61
S&P BSE Power 1,505 1,482 23 1.53
10,801 10,544 257 2.44
S&P BSE HC 14,890 14,994 -103 -0.69
Date P/E Div. Yield P/E Div. Yield
17-Apr 19.16 1.37 20.85 1.64
Month Ago 18.55 1.44 20.41 1.70
Year Ago 28.32 1.11 29.42 1.12
Nifty 50 Top 3 Gainers
Company 17-Apr Prev_Day
Axis Bank 479 423 13.31
Eicher Motors 14770 13371 10.46
ICICI Bank 376 342 9.81
Nifty 50 Top 3 Losers Domestic News
Company 17-Apr Prev_Day
Nestle India Limited 17324 17895 -3.19
HUL 2385 2436 -2.10
Bharti Infratel 168 172 -1.87
Advance Decline Ratio
Advances 1716 1398
Declines 714 446
Unchanged 163 116
Institutional Flows (Equity)
FII Flows* -51839
MF Flows** 35848
Apr 2020; **13
YoY(%) Current Year Ago
Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
Since May-17, MOSPI has revised base year of IIP & WPI from 2004-05 to 2011-12, and for CPI from
2010 to 2012
• Indian equity markets soared after the Reserve Bank of India (RBI)
announced a host of stimulus measures to support the economy in the
wake of coronavirus outbreak. Among the measures, the central bank
slashed reverse repo rate by 25 basis points to 3.75%. It also announced
special refinance facility of Rs 15,000 crore to SIDBI; Rs 25,000 crore to
NABARD, and Rs 10,000 crore to HFCs to support liquidity.
• Key benchmark indices S&P BSE Sensex and Nifty 50 gained 3.22% and
3.05% to close at 31,588.72 and 9,266.75 respectively. S&P BSE MidCap and
S&P BSE SmallCap gained 2.12% and 2.44% respectively.
• The overall market breadth on BSE was strong with 1,716 scrips advancing
and 714 scrips declining. A total of 163 scrips remained unchanged.
• On the BSE sectoral front, S&P BSE Bankex was the major gainer, up 6.83%
followed by S&P BSE Finance, up 5.44% and S&P BSE Auto, up 4.67%. S&P
BSE FMCG was the major loser, down 0.99% followed by S&P BSE
Healthcare, down 0.69%.
• The Reserve Bank of India (RBI) lowered the reverse repo rate from 4% to
3.75%. The objective of the move is to discourage banks from parking their
funds in the reverse repo and instead deploy the surplus funds as loans or
investments in the productive sectors of the economy. The key policy repo
rate remains unchanged at 4.40% while the marginal standing facility rate
and the bank rate remain unchanged at 4.65%.
• RBI announced to conduct targeted long-term repo operations (TLTRO 2.0)
for an aggregate amount of Rs. 50,000 crore in tranches of appropriate
sizes of which at least 50% will be targeted towards mid and small sized
non-banking finance companies (NBFCs) and microfinance institutions
• RBI has decided to increase the ways and means advances (WMA) limit of
states by 60% over and above the level as on Mar 31, 2020. This increased
limit will be available till Sep 30, 2020. The objective of the move is to assist
states in combating the COVID-19 pandemic and help them plan their
borrowings from the markets.
• RBI in order to ease liquidity woes at the institutional levels, reduced the
Liquidity Coverage Ratio (LCR) requirement for scheduled commercial
banks from 100% to 80% with immediate effect. However, the same will be
gradually restored back in two phases, - 90% by Oct 1, 2020 and 100% by
Apr 1, 2021. In addition, RBI barred banks from paying any dividend from
their profits for the fiscal ended Mar 31, 2020 as it underlined the
importance of capital conservation in order to provide support to the
domestic economy amid the ongoing COVID-19 pandemic.
• Tata Consultancy Services announced 0.94% YoY fall in profit at Rs. 8,049
crore for the quarter ending Mar 31, 2020. The board of the company also
announced a final dividend of Rs 6. Consolidated revenue of the company
rose 5% on a yearly basis to Rs. 39,946 crore.
• Larsen & Tourbro announced that its buildings and factories business has
bagged important orders from domestic clients worth up to Rs. 2,500
• Asian markets closed on a positive note as reports of promising initial data
related to a potential COVID-19 treatment from a U.S. based bio-
technology company and U.S. President 's plans to reopen businesses
helped investors shrug off weak economic data from China. Today (as on
Apr 20) markets traded low ahead of the release of China’s loan prime rate.
Both Nikkei and Hang Seng are down by 1.02% and 0.36%, respectively (as
at 8.a.m. IST).
• European markets too witnessed buying spree after a report that a drug
developed by a U.S. based biopharma company has shown effectiveness in
treating the coronavirus.
• U.S. markets rose after a U.S. based biopharma company reported that its
drug has shown effectiveness in treating the coronavirus. The news gave
investors hope of a treatment solution that shall help the country to
reopen faster from the widespread shutdowns.